XML 38 R27.htm IDEA: XBRL DOCUMENT v3.19.2
STOCK AWARD PLANS (Tables)
6 Months Ended
Jun. 30, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Compensation Cost Breakdown in Statement of Earnings The Company has share-based compensation plans which are described below. The compensation cost that has been charged against earnings for the Company’s stock award plans and the income tax benefit recognized in the statement of earnings for stock awards for the three months and six months ended June 30, 2019 and 2018 were as follows (in thousands):


 
Three months ended
June 30,
   
Six months ended
June 30,
 
   
2019
   
2018
   
2019
   
2018
 
Compensation cost
 
$
3,007
   
$
6,000
   
$
7,907
   
$
13,551
 
Income tax benefit
 
$
740
   
$
2,278
   
$
1,909
   
$
4,038
 

Stock Option Valuation Assumptions The key input variables used in valuing the options during the six months ended June 30, 2019 and 2018 were as follows:


 
Six months ended
June 30,
 
   
2019
   
2018
 
Dividend yield
 
None
   
None
 
Average risk-free interest rate
   
2.5
%
   
2.7
%
Stock price volatility
   
28
%
   
27
%
Estimated option term
 
5.3 years
   
5.5 years
 

Employee Plan [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Stock Option Activity The following is a summary of the stock option activity under the employee plan described above for the six months ended June 30, 2019:


 
Outstanding
Non-
Qualified or
Nonincentive
Stock
Awards
   
Weighted
Average
Exercise
Price
 
Outstanding at December 31, 2018
   
464,702
   
$
69.85
 
Granted
   
114,429
   
$
74.57
 
Exercised
   
(26,890
)
 
$
64.15
 
Canceled or expired
   
(16,498
)
 
$
72.56
 
Outstanding at June 30, 2019
   
535,743
   
$
71.06
 

Outstanding and Exercisable Stock Options

The following table summarizes information about the Company’s outstanding and exercisable stock options under the employee plan at June 30, 2019:

 
 
Options Outstanding
 
Options Exercisable
Range of Exercise
Prices
 
Number
Outstanding
 
 
Weighted
Average
Remaining
Contractual
Life in Years
 
 
Weighted
Average
Exercise Price
 
Aggregate
Intrinsic Value
 
Number
Exercisable
 
 
Weighted
Average
Exercise Price
 
Aggregate
Intrinsic Value
$51.23
 
 
83,329
 
 
 
3.6
 
 
$
51.23
 
 
 
 
83,329
 
 
$
51.23
 
  
$64.65 - $68.50
   
100,757
     
5.0
   
$
67.34
       
45,052
   
$
68.47
   
$70.65 - $75.50
 
 
307,671
 
 
 
4.9
 
 
$
74.32
 
 
 
 
126,553
 
 
$
73.96
 
  
$84.90 - $101.46
 
 
43,986
 
 
 
2.4
 
 
$
94.38
 
 
 
 
37,281
 
 
$
96.08
 
  
$51.23 - $101.46
 
 
535,743
 
 
 
4.5
 
 
$
71.06
 
$4,929,000
 
 
292,215
 
 
$
69.45
 
$3,426,000

Restricted Stock Award Activity

The following is a summary of the restricted stock award activity under the employee plan described above for the six months ended June 30, 2019:


 
Unvested
Restricted
Stock
Award
Shares
   
Weighted
Average
Grant Date
Fair
Value
Per Share
 
Nonvested balance at December 31, 2018
   
214,216
   
$
64.73
 
Vested
   
(62,406
)
 
$
68.30
 
Forfeited
   
(12,205
)
 
$
63.36
 
Nonvested balance at June 30, 2019
   
139,605
   
$
63.26
 

RSU Activity



 
Unvested RSUs
   
Weighted
Average Grant
Date Fair Value
Per Unit
 
Nonvested balance at December 31, 2018
   
141,055
   
$
75.59
 
Granted
   
146,005
   
$
74.44
 
Vested
   
(25,484
)
 
$
75.60
 
Forfeited
   
(4,754
)
 
$
75.31
 
Nonvested balance at June 30, 2019
   
256,822
   
$
74.94
 

The following is a summary of the stock option activity under the director plan described above for the six months ended June 30, 2019:


 
Outstanding
Non-Qualified
or Nonincentive
Stock Options
   
Weighted
Average
Exercise Price
 
Outstanding at December 31, 2018
   
131,104
   
$
70.14
 
Granted
   
2,652
   
$
84.90
 
Exercised
   
(6,000
)
 
$
29.60
 
Outstanding at June 30, 2019
   
127,756
   
$
72.35
 

Director Plan [Member]  
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]  
Stock Option Activity

The following is a summary of the stock option activity under the director plan described above for the six months ended June 30, 2019:


 
Outstanding
Non-Qualified
or Nonincentive
Stock Options
   
Weighted
Average
Exercise Price
 
Outstanding at December 31, 2018
   
131,104
   
$
70.14
 
Granted
   
2,652
   
$
84.90
 
Exercised
   
(6,000
)
 
$
29.60
 
Outstanding at June 30, 2019
   
127,756
   
$
72.35
 

Outstanding and Exercisable Stock Options The following table summarizes information about the Company’s outstanding and exercisable stock options under the director plan at June 30, 2019:

 
 
Options Outstanding
 
Options Exercisable
Range of Exercise
Prices
 
Number
Outstanding
 
 
Weighted
Average
Remaining
Contractual
Life in Years
 
 
Weighted
Average
Exercise Price
 
Aggregate
Intrinsic Value
 
Number
Exercisable
 
 
Weighted
Average
Exercise Price
 
Aggregate
Intrinsic Value
$41.24 – $56.45
 
 
31,276
 
 
 
1.4
 
 
$
50.61
 
 
 
 
31,276
 
 
$
50.61
 
  
$61.89 – $62.48
 
 
28,000
 
 
 
3.1
 
 
$
62.27
 
 
 
 
28,000
 
 
$
62.27
 
  
$70.65 – $99.52
 
 
68,480
 
 
 
4.9
 
 
$
86.39
 
 
 
 
66,491
 
 
$
86.44
 
  
$41.24 – $99.52
 
 
127,756
 
 
 
3.6
 
 
$
72.35
 
$1,498,000
 
 
125,767
 
 
$
72.15
 
$ 1,498,000

Restricted Stock Award Activity The following is a summary of the restricted stock award activity under the director plan described above for the six months ended June 30, 2019:


 
Unvested
Restricted
Stock Award
Shares
   
Weighted
Average
Grant Date
Fair Value
Per Share
 
Nonvested balance at December 31, 2018
   
264
   
$
85.30
 
Granted
   
21,064
   
$
84.90
 
Vested
   
(794
)
 
$
85.03
 
Nonvested balance at June 30, 2019
   
20,534
   
$
84.90